Emma Zattarin
Bergamo, 24125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study.
Journal: Familial cancer
Published: December 15, 2025
Association between risk-reducing salpingooophorectomy and bone health in women with hereditary breast and ovarian cancer syndrome.
Journal: Menopause (New York, N.Y.)
Published: November 18, 2025
Bridging language barriers in global oncology: toward more inclusive scientific communication.
Journal: ESMO open
Published: October 16, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer.
Journal: NPJ breast cancer
Published: August 28, 2025
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.
Journal: JCO global oncology
Published: July 01, 2025
Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.
Journal: Breast (Edinburgh, Scotland)
Published: December 30, 2024
Gender-based differences in the efficacy of anti-EGFR/BRAF/MEK targeted therapy in patients with BRAF-mutated metastatic colorectal cancer.
Journal: Seminars in oncology
Published: January 06, 2024
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis.
Journal: EClinicalMedicine
Published: September 16, 2023
Last Updated: 09/26/2026